Literature DB >> 2039713

Cell cycle and electron microscopic evaluation of the adenocarcinoma antigen recognised by the monoclonal antibody 44-3A6.

J A Radosevich1, F S Siddiqui, S T Rosen, W J Kabat.   

Abstract

Adenocarcinomas represent one group of tumours which are seen in the broad spectrum of pulmonary neoplasms. We have produced a monoclonal antibody (44-3A6) which reacts with a 40 kD protein expressed by human primary pulmonary adenocarcinomas and cell lines. Using FACS analysis, this antigen does not appear to be cell cycle specific, and is exposed to the external cell surface. This subcellular localisation has been confirmed using a whole cell, pre-embedding, EM-immunogold labelling technique.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039713      PMCID: PMC2204118     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  3 in total

1.  Monoclonal antibody 44-3A6 as a probe for a novel antigen found on human lung carcinomas with glandular differentiation.

Authors:  J A Radosevich; Y X Ma; I Lee; H R Salwen; V E Gould; S T Rosen
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

2.  Expression of the antigenic determinant recognized by the monoclonal antibody 44-3A6 on select human adenocarcinomas and normal human tissues.

Authors:  S G Combs; J A Radosevich; Y Ma; I Lee; V E Gould; H Battifora; S T Rosen
Journal:  Tumour Biol       Date:  1988

3.  Immunohistochemical analysis of human adenocarcinomas of the lung using the monoclonal antibody 44-3A6.

Authors:  J A Radosevich; M Noguchi; S T Rosen; Y Shimosato
Journal:  Tumour Biol       Date:  1990
  3 in total
  1 in total

1.  Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen.

Authors:  Michael Babich; Ankit Sharma; Tianhong Li; James A Radosevich
Journal:  Heliyon       Date:  2022-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.